{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T22:32:34Z","timestamp":1794868354012,"version":"4.9.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"German Federal Ministry of Research","award":["16LW0472K"],"award-info":[{"award-number":["16LW0472K"]}]},{"name":"German Federal Ministry of Research","award":["16LW0472K"],"award-info":[{"award-number":["16LW0472K"]}]},{"name":"German Federal Ministry of Research","award":["16LW0472K"],"award-info":[{"award-number":["16LW0472K"]}]},{"name":"German Federal Ministry of Research","award":["16LW0472K"],"award-info":[{"award-number":["16LW0472K"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-025-01759-x","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T08:14:27Z","timestamp":1747901667000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Novel fully human high-affinity anti-TREM2 antibody shows efficacy in clinically relevant Alzheimer\u00b4s mouse model"],"prefix":"10.1186","volume":"17","author":[{"given":"Markus","family":"Kraller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Fa\u00dfbender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"Jabali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Kroeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastian","family":"Popper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Ungerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam A.","family":"Christlmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"key":"1759_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2022.937486","volume":"14","author":"X Li","year":"2022","unstructured":"Li X, Feng X, Sun X, Hou N, Han F, Liu Y. Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990\u20132019. Front Aging Neurosci. 2022;14:1\u201317.","journal-title":"Front Aging Neurosci"},{"issue":"13","key":"1759_CR2","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.15252\/embj.201796516","volume":"36","author":"G Kleinberger","year":"2017","unstructured":"Kleinberger G, Brendel M, Mracsko E, Wefers B, Groeneweg L, Xiang X, et al. The FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism. EMBO J. 2017;36(13):1837\u201353.","journal-title":"EMBO J"},{"issue":"4","key":"1759_CR3","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","volume":"170","author":"TK Ulland","year":"2017","unstructured":"Ulland TK, Song WM, Huang SCC, Ulrich JD, Sergushichev A, Beatty WL, et al. TREM2 Maintains Microglial Metabolic Fitness in Alzheimer\u2019s Disease. Cell. 2017;170(4):649-663.e13.","journal-title":"Cell"},{"issue":"4","key":"1759_CR4","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jalz.2016.07.004","volume":"13","author":"W Song","year":"2017","unstructured":"Song W, Hooli B, Mullin K, Jin SC, Cella M, Ulland TK, et al. Alzheimer\u2019s disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation. Alzheimer\u2019s and Dementia. 2017;13(4):381\u20137.","journal-title":"Alzheimer\u2019s and Dementia"},{"issue":"10","key":"1759_CR5","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.15252\/emmm.201707672","volume":"9","author":"K Schlepckow","year":"2017","unstructured":"Schlepckow K, Kleinberger G, Fukumori A, Feederle R, Lichtenthaler SF, Steiner H, et al. An Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function. EMBO Mol Med. 2017;9(10):1356\u201365.","journal-title":"EMBO Mol Med"},{"issue":"2","key":"1759_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, et al. TREM2 Variants in Alzheimer\u2019s Disease. New Engl J Med. 2013;368(2):117\u201327.","journal-title":"New Engl J Med"},{"issue":"2","key":"1759_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, et al. Variant of TREM2 Associated with the Risk of Alzheimer\u2019s Disease. New Engl J Med. 2013;368(2):107\u201316.","journal-title":"New Engl J Med"},{"issue":"7","key":"1759_CR8","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, et al. A Unique Microglia Type Associated with Restricting Development of Alzheimer\u2019s Disease. Cell. 2017;169(7):1276-1290.e17.","journal-title":"Cell"},{"issue":"46","key":"1759_CR9","doi-asserted-by":"publisher","first-page":"33027","DOI":"10.1074\/jbc.M113.517540","volume":"288","author":"P Wunderlich","year":"2013","unstructured":"Wunderlich P, Glebov K, Kemmerling N, Tien NT, Neumann H, Walter J. Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and \u03b3-secretase- dependent intramembranous cleavage. J Biol Chem. 2013;288(46):33027\u201336.","journal-title":"J Biol Chem"},{"issue":"243","key":"1759_CR10","doi-asserted-by":"publisher","first-page":"ra86","DOI":"10.1126\/scitranslmed.3009093","volume":"6","author":"G Kleinberger","year":"2014","unstructured":"Kleinberger G, Yamanishi Y, Su\u00e1rez-Calvet M, Czirr E, Lohmann E, Cuyvers E, et al. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Sci Transl Med. 2014;6(243):ra86.","journal-title":"Sci Transl Med"},{"key":"1759_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2019.00328","volume":"11","author":"L Zhong","year":"2019","unstructured":"Zhong L, Chen XF. The Emerging Roles and Therapeutic Potential of Soluble TREM2 in Alzheimer\u2019s Disease. Front Aging Neurosci. 2019;11:1\u20139.","journal-title":"Front Aging Neurosci"},{"issue":"10","key":"1759_CR12","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.15252\/emmm.201707673","volume":"9","author":"P Thornton","year":"2017","unstructured":"Thornton P, Sevalle J, Deery MJ, Fraser G, Zhou Y, St\u00e5hl S, et al. TREM 2 shedding by cleavage at the H157\u2013S158 bond is accelerated for the Alzheimer\u2019s disease-associated H157Y variant. EMBO Mol Med. 2017;9(10):1366\u201378.","journal-title":"EMBO Mol Med"},{"key":"1759_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.neulet.2017.09.034","volume":"660","author":"D Feuerbach","year":"2017","unstructured":"Feuerbach D, Schindler P, Barske C, Joller S, Beng-Louka E, Worringer KA, et al. ADAM17 is the main sheddase for the generation of human triggering receptor expressed in myeloid cells (hTREM2) ectodomain and cleaves TREM2 after Histidine 157. Neurosci Lett. 2017;660:109\u201314.","journal-title":"Neurosci Lett"},{"key":"1759_CR14","doi-asserted-by":"crossref","unstructured":"Schlepckow K, Monroe KM, Kleinberger G, Cantuti\u2010Castelvetri L, Parhizkar S, Xia D, et al. Enhancing protective microglial activities with a dual function TREM 2 antibody to the stalk region. EMBO Mol Med. 2020;12(4)e11227: 1\u201322.","DOI":"10.15252\/emmm.201911227"},{"key":"1759_CR15","first-page":"416","volume":"26","author":"B van Lengerich","year":"2023","unstructured":"van Lengerich B, Zhan L, Xia D, Chan D, Joy D, Joshua I, et al. A TREM2-activating antibody with a blood \u2013 brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u2019s disease models. Nature Neurosci. 2023;26:416\u201329.","journal-title":"Nature Neurosci"},{"key":"1759_CR16","doi-asserted-by":"crossref","unstructured":"Wang S, Mustafa M, Yuede CM, Salazar SV, Kong P, Long H, et al. Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer\u2019s disease model. J Exp Med. 2020; 217(9)e20200785:1\u201319.","DOI":"10.1084\/jem.20200785"},{"issue":"1","key":"1759_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-020-01980-5","volume":"18","author":"M Fassler","year":"2021","unstructured":"Fassler M, Rappaport MS, Cu\u00f1o CB, George J. Engagement of TREM2 by a novel monoclonal antibody induces activation of microglia and improves cognitive function in Alzheimer\u2019s disease models. J Neuroinflamm. 2021;18(1):1\u201318.","journal-title":"J Neuroinflamm"},{"key":"1759_CR18","doi-asserted-by":"crossref","unstructured":"Ellwanger DC, Wang S, Brioschi S, Shao Z, Green L, Case R, et al. Prior activation state shapes the microglia response to antihuman TREM2 in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2021;118(3)e2017742118: 1\u201312.","DOI":"10.1073\/pnas.2017742118"},{"issue":"1","key":"1759_CR19","doi-asserted-by":"publisher","first-page":"e20220654: 1\u201313","DOI":"10.1084\/jem.20220654","volume":"220","author":"N Jain","year":"2023","unstructured":"Jain N, Lewis CA, Ulrich JD, Holtzman DM. Chronic TREM2 activation exacerbates A\u03b2-associated tau seeding and spreading. J Exp Med. 2023;220(1):e20220654: 1-13.","journal-title":"J Exp Med"},{"issue":"661","key":"1759_CR20","doi-asserted-by":"publisher","first-page":"eabq0095: 1\u201315","DOI":"10.1126\/scitranslmed.abq0095","volume":"14","author":"P Zhao","year":"2022","unstructured":"Zhao P, Xu Y, Jiang LL, Fan X, Li L, Li X, et al. A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer\u2019s disease. Sci Transl Med. 2022;14(661):eabq0095: 1-15.","journal-title":"Sci Transl Med"},{"issue":"1","key":"1759_CR21","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12974-020-01915-0","volume":"17","author":"BR Price","year":"2020","unstructured":"Price BR, Sudduth TL, Weekman EM, Johnson S, Hawthorne D, Woolums A, et al. Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition. J Neuroinflamm. 2020;17(1):238.","journal-title":"J Neuroinflamm"},{"issue":"5","key":"1759_CR22","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1084\/jem.20151948","volume":"213","author":"Y Wang","year":"2016","unstructured":"Wang Y, Ulland TK, Ulrich JD, Song W, Tzaferis JA, Hole JT, et al. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J Exp Med. 2016;213(5):667\u201375.","journal-title":"J Exp Med"},{"issue":"suppl 1","key":"1759_CR23","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.3909\/ricm19S1S0002","volume":"19","author":"EM Roth","year":"2018","unstructured":"Roth EM, Davidson MH. PCSK9 inhibitors: Mechanism of action, efficacy, and safety. Rev Cardiovasc Med. 2018;19(suppl 1):S31\u201346.","journal-title":"Rev Cardiovasc Med"},{"issue":"20","key":"1759_CR24","doi-asserted-by":"publisher","first-page":"9036","DOI":"10.1073\/pnas.88.20.9036","volume":"88","author":"MS Chappel","year":"1991","unstructured":"Chappel MS, Isenman DE, Everett M, Xu YY, Dorrington KJ, Klein MH. Identification of the Fc, receptor class I binding site in human IgG through the use of recombinant IgG1\/IgG2 hybrid and point-mutated antibodies. Proc Nat Acad Sci USA. 1991;88(20):9036\u201340.","journal-title":"Proc Nat Acad Sci USA"},{"issue":"545","key":"1759_CR25","doi-asserted-by":"publisher","first-page":"eaay1359: 1\u201314","DOI":"10.1126\/scitranslmed.aay1359","volume":"12","author":"MS Kariolis","year":"2020","unstructured":"Kariolis MS, Wells RC, Getz JA, Kwan W, Mahon CS, Tong R, et al. Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys. Sci Transl Med. 2020;12(545):eaay1359: 1-14.","journal-title":"Sci Transl Med"},{"issue":"5","key":"1759_CR26","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.neuron.2020.09.029","volume":"108","author":"JW Lewcock","year":"2020","unstructured":"Lewcock JW, Schlepckow K, Di PG, Tahirovic S, Monroe M, Haass C. Emerging microglia biology defines novel therapeutic approaches for neurodegenerative diseases. Neuron. 2020;108(5):801\u201321.","journal-title":"Neuron"},{"issue":"4","key":"1759_CR27","doi-asserted-by":"publisher","first-page":"e11227","DOI":"10.15252\/emmm.201911227","volume":"12","author":"K Schlepckow","year":"2020","unstructured":"Schlepckow K, Monroe KM, Kleinberger G, Cantuti-Castelvetri L, Parhizkar S, Xia D, et al. Enhancing protective microglial activities with a dual function TREM 2 antibody to the stalk region. EMBO Mol Med. 2020;12(4):e11227.","journal-title":"EMBO Mol Med"},{"issue":"9","key":"1759_CR28","doi-asserted-by":"publisher","first-page":"e20200785","DOI":"10.1084\/jem.20200785","volume":"217","author":"S Wang","year":"2020","unstructured":"Wang S, Mustafa M, Yuede CM, Salazar SV, Kong P, Long H, et al. Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer\u2019s disease model. J Exp Med. 2020;217(9):e20200785.","journal-title":"J Exp Med"},{"issue":"4","key":"1759_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096340","volume":"9","author":"H Sade","year":"2014","unstructured":"Sade H, Baumgartner C, Hugenmatter A, Moessner E, Freskg\u00e5rd PO, Niewoehner J. A human blood-brain barrier transcytosis assay reveals antibody transcytosis influenced by pH-dependent receptor binding. PLoS ONE. 2014;9(4): e96340.","journal-title":"PLoS ONE"},{"key":"1759_CR30","unstructured":"Moscardo E, Salvetti B, Becchi S, Bertini G, Fabene PF. The NOR test in rodents - which are the essential methodological aspects? Proc Measure Behav 2012; 476\u2013478."},{"key":"1759_CR31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.nlm.2018.02.027","volume":"150","author":"B Popper","year":"2018","unstructured":"Popper B, Demleitner A, Bolivar VJ, Kusek G, Snyder-Keller A, Schieweck R, et al. Staufen2 deficiency leads to impaired response to novelty in mice. Neurobiol Learn Mem. 2018;150:107\u201315.","journal-title":"Neurobiol Learn Mem"},{"issue":"40","key":"1759_CR32","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal \u03b2-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: Potential factors in amyloid plaque formation. J Neurosci. 2006;26(40):10129\u201340.","journal-title":"J Neurosci"},{"issue":"12","key":"1759_CR33","doi-asserted-by":"publisher","first-page":"6766","DOI":"10.3390\/ijms25126766","volume":"25","author":"MS P\u00e1dua","year":"2024","unstructured":"P\u00e1dua MS, Guil-Guerrero JL, Lopes PA. Behaviour Hallmarks in Alzheimer\u2019s Disease 5xFAD Mouse Model. Int J Mol Sci. 2024;25(12):6766.","journal-title":"Int J Mol Sci"},{"key":"1759_CR34","doi-asserted-by":"crossref","unstructured":"Zhao P, Xu Y, Fan X, Li L, Li X, Arase H, et al. Discovery and engineering of an anti-TREM2 antibody to promote amyloid plaque clearance by microglia in 5XFAD mice. MAbs []. 2022;14(1):1\u201317.","DOI":"10.1080\/19420862.2022.2107971"},{"issue":"2","key":"1759_CR35","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3233\/JAD-200637","volume":"79","author":"H Fanet","year":"2021","unstructured":"Fanet H, Tournissac M, Leclerc M, Caron V, Tremblay C, Vancassel S, et al. Tetrahydrobiopterin Improves Recognition Memory in the Triple-Transgenic Mouse Model of Alzheimer\u2019s Disease Without Altering Amyloid-\u03b2 and Tau Pathologies. J Alzheimers Dis. 2021;79(2):709\u201327.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"1759_CR36","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nbt0498-376","volume":"16","author":"H Bothmann","year":"1998","unstructured":"Bothmann H, Pl\u00fcckthun A. Selection for a periplasmic factor improving phage display and functional periplasmic expression. Nat Biotechnol. 1998;16(4):376\u201380.","journal-title":"Nat Biotechnol"},{"issue":"8","key":"1759_CR37","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1016\/j.drudis.2022.05.002","volume":"27","author":"A Ljungars","year":"2022","unstructured":"Ljungars A, Rimbault C, S\u00f8rensen V, Tulika T, Wade J, Wouters Y, et al. Advances in antibody phage display technology. Drug Discov Today. 2022;27(8):2151\u201369.","journal-title":"Drug Discov Today"},{"issue":"2","key":"1759_CR38","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.neuron.2017.03.042","volume":"94","author":"EM Abud","year":"2017","unstructured":"Abud EM, Ramirez RN, Martinez ES, Healy LM, Nguyen CHH, Newman SA, et al. iPSC-Derived Human Microglia-like Cells to Study Neurological Diseases. Neuron. 2017;94(2):278\u201393.","journal-title":"Neuron"},{"issue":"1","key":"1759_CR39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13024-018-0297-x","volume":"13","author":"A McQuade","year":"2018","unstructured":"McQuade A, Coburn M, Tu CH, Hasselmann J, Davtyan H, Blurton-Jones M. Development and validation of a simplified method to generate human microglia from pluripotent stem cells. Mol Neurodegener. 2018;13(1):67.","journal-title":"Mol Neurodegener"},{"issue":"6512","key":"1759_CR40","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1126\/science.abb8575","volume":"370","author":"A Sierksma","year":"2020","unstructured":"Sierksma A, Escott-Price V, De Strooper B. Translating genetic risk of Alzheimer\u2019s disease into mechanistic insight and drug targets. Science. 2020;370(6512):61\u20136.","journal-title":"Science"},{"key":"1759_CR41","doi-asserted-by":"crossref","unstructured":"Martin Lorenzo S, Nalesso V, Chevalier C, Birling MC, Herault Y. Targeting the RHOA pathway improves learning and memory in adult Kctd13 and 16p11.2 deletion mouse models. Mol Autism. 2021;12(1):1;1\u201313.","DOI":"10.1186\/s13229-020-00405-7"},{"key":"1759_CR42","doi-asserted-by":"crossref","unstructured":"Carpenter AE, Jones TR, Lamprecht MR, Clarke C, Kang IH, Friman O, et al. CellProfiler: Image analysis software for identifying and quantifying cell phenotypes. Genome Biol 2006;7(10):R100.1-R100.11.","DOI":"10.1186\/gb-2006-7-10-r100"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01759-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01759-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01759-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T08:14:33Z","timestamp":1747901673000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01759-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1759"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01759-x","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"23 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were permitted by the local Ethics board in accordance with European and German animal welfare legislations (5.1\u2013231 5682\/LMU\/BMC\/CAM). The most recent version of the Animal Research: Reporting In Vivo Experiments (ARRIVE) guidelines was strictly followed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Several authors are employees of the biotech company ISAR Bioscience which is, however, owned (100%) by a non-profit foundation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}